Cargando…
Increased expression of Nrf2 and elevated glucose uptake in pheochromocytoma and paraganglioma with SDHB gene mutation
BACKGROUND: Pheochromocytomas (PCC) and paragangliomas (PGL) are catecholamine-producing neuroendocrine tumors. According to the World Health Organization Classification 2017, all PCC/PGL are considered to have malignant potential. There is growing evidence that PCC/PGL represent a metabolic disease...
Autores principales: | Kamai, Takao, Murakami, Satoshi, Arai, Kyoko, Nishihara, Daisaku, Uematsu, Toshitaka, Ishida, Kazuyuki, Kijima, Toshiki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931959/ https://www.ncbi.nlm.nih.gov/pubmed/35300626 http://dx.doi.org/10.1186/s12885-022-09415-5 |
Ejemplares similares
-
Presurgical avelumab plus axitinib in an immunosenescent octogenarian with renal cell carcinoma invading the vena cava
por: Uematsu, Toshitaka, et al.
Publicado: (2022) -
Association of Nrf2 expression and mutation with Weiss and Helsinki scores in adrenocortical carcinoma
por: Kamai, Takao, et al.
Publicado: (2022) -
Increased co-expression of stromal HHLA2 and fibroblast activation protein in upper tract urothelial carcinoma
por: Nishihara, Daisaku, et al.
Publicado: (2023) -
Targeting NRF2-Governed Glutathione Synthesis for SDHB-Mutated Pheochromocytoma and Paraganglioma
por: Liu, Yang, et al.
Publicado: (2020) -
A case of clear cell renal cell carcinoma with vena cava thrombus responding to presurgical avelumab, and axitinib
por: Suzuki, Issei, et al.
Publicado: (2021)